121 filings
Page 2 of 7
8-K
lc7 3mejxh348qf
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
si9nh4h
27 Oct 23
Material Modifications to Rights of Security Holders
4:15pm
8-K
1msxicx68o5fc
25 Sep 23
Submission of Matters to a Vote of Security Holders
9:00am
8-K
aclwtiaatewwzys40
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:10pm
DEFA14A
939hip55f
14 Sep 23
Additional proxy soliciting materials
4:38pm
DEFA14A
t98w66
6 Sep 23
Additional proxy soliciting materials
5:26pm
8-K
vmc0qo41t2wz2i ql
21 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
PRE 14A
o4ioq9l8zfr7nkwnrvti
16 Aug 23
Preliminary proxy
4:45pm
8-K
bcjj0ip
16 Aug 23
Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
4:30pm
NT 10-Q
2nmquu2
14 Aug 23
Notice of late quarterly filing
7:46pm
8-K
c6l 3mbd6411lxsolmm9
8 Jun 23
Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update
5:00pm
8-K
i3l9 qn5wtymv
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
NT 10-Q
rbbqfgy4 me
15 May 23
Notice of late quarterly filing
4:01pm
8-K
up90q44jzc9
9 May 23
Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations
4:05pm
8-K
2few3cop5w939t
30 Mar 23
Vivos Therapeutics Reports Fourth Quarter and Full Year 2022
5:14pm
8-K
pcbfss 0a73uwfi
27 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00am